The study is designed to identify the best way to treat pulmonary embolism, specifically when there is a large amount of clot but the patient's blood pressure ...

PE-TRACT is a parallel-group, open-label, phase 3 RCT. Patients will be randomized 1:1 to receive either CDT or no therapy (ie, anticoagulants alone), with ...

PE-TRACT would be the largest study to date (approximately 500 patients) of CDT for PE, and its rigorous, randomized comparison of CDT to AC alone is exactly ...

We have identified several key challenges to conducting PE-TRACT using a traditional trial design: 1) identifying the optimal primary outcome; 2) determining ...

PE-TRACT is a clinical trial comparing two standard treatment options for pulmonary embolism: blood thinner medicine and catheter-directed therapy.

PE-TRACT is an open-label, assessor-blinded, randomized trial, aiming to compare catheter-directed therapy (CDT) and anticoagulation (CDT group) with ...

PE-TRACT is an open-label, assessor-blinded, randomized trial, aiming to compare catheter-directed therapy (CDT) and anticoagulation (CDT group) with ...

Site for PE TRACT is an open-label, assessor-blinded, randomized trial, aiming to compare CDT and anticoagulation (CDT group) with anticoagulation alone ...

2 мая 2024 г. · The NIH-funded landmark PE-TRACT trial, testing catheter-directed therapy for submassive PE, is in full swing. Dr. Sista, the trial's national ...

The PE-TRACT trial (NCT0591118) seeks to determine whether CDT improves cardiopulmonary health in the year following PE compared to AC alone. These ...